7723f502_s___Medical_Oncologists___ESMO__Topic
[Date] 02 Apr 2014 [Title] Next Generation ALK Inhibitor for ALK-Rearranged Non–Small Cell Lung Cancer [Topic] 
Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
Oncology News | Medical Oncologists | ESMO